Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
MACs Propose Limiting Coverage for iDose TR
Five Medicare administrative contractors (MACs) in the US are proposing to limit coverage for procedures implanting the Glaukos iDose TR in patients with glaucoma. The iDose TR is a drug-eluting in...
Viridian Announces US FDA Approval and Launch of Lumvoa for Thyroid Eye Disease
Viridian Therapeutics announced June 29 that the US FDA had approved Lumvoa (veligrotug-vvze), an infusion treatment for thyroid eye disease (TED). The Waltham, Massachusetts, company said it would...
Lenz Licenses Vizz Presbyopia Drops to Arrotex for Australia, New Zealand
Lenz Therapeutics announced June 24 that it had granted Arrotex Pharmaceuticals exclusive rights to develop Vizz (aceclidine ophthalmic solution) 1.44% eye drops for presbyopia in Australia and New...
LambdaVision Collaborates with Vast, Creator of Planned Commercial Space Station
LambdaVision reported June 24 that it had signed a memorandum of understanding with Vast related to future research and manufacturing activities for LambdaVision’s artificial retina aboard Vast’s p...
Supreme Court Ruling in Favor of Bayer May Shut Down Thousands of Roundup Lawsuits
German company Bayer won a landmark ruling in the US Supreme Court on June 25, when justices ruled 7-2 that federal pesticide laws preempt “failure-to-warn” claims made under state law. The plainti...
Optos Celebrates Milestone of 30 Thousand Installed Imaging Devices
UK-based Optos reported June 25 that it had reached the milestone of 30 thousand imaging devices installed globally. The company developed and continues to be a leader in single-capture, 200-degree...
BVI Opens Experience Hub for Ophthalmic Training, Collaboration
BVI Medical, of Waltham, Massachusetts, announced June 15 that it had opened a new BVI Experience Hub within its offices in Sant Cugat, Spain. The hub is designed to support ophthalmic training and...
Braille Institute Names Six Recipients of Community Hero Awards
The Braille Institute of America honored six recipients of its Community Hero Awards at a dinner on June 25. The awards recognize extraordinary organizations and leaders for breaking barriers, expa...
Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking
Vermont has become the 17th US state to pass a law expanding optometrists’ scope of practice to include in-office laser procedures. Senate Bill 64, signed into law by Gov. Phil Scott on June 18, gr...
Théa Pharma Launches Zolymbus Bimatoprost Gel for Glaucoma in the US
Théa Pharma, the Massachusetts-based subsidiary of France-based Théa, announced June 15 that it had launched Zolymbus (bimatoprost ophthalmic gel) 0.01% in the US. Thepreservative-free formulation ...
Hexiris Showcases Glaucoma Devices Targeting Office-Based Surgery
Canada’s Hexiris Ophthalmics reports that it is showcasing at ophthalmic meetings its glaucoma device candidates targeting office-based surgery, with an eye toward a commercial launch in 2026. Surg...
EBAA Annual Meeting Underlines Human Impact of Donation
The 2026 Eye Bank Association of America (EBAA) annual meeting brought together approximately 250 eye bank technicians, medical directors, corneal surgeons, and industry professionals June 3-6 in I...
Past News Stories
Formosa Licenses Clobetasol Drops to Samil for Vietnam
Taiwan-based Formosa Pharmaceuticals announced June 11 that it had expanded its licensing agreement with Samil Pharmaceuticals for clobetasol propionate 0.05% eye drops for postsurgical inflammatio...
Scope Health Adds Vision Support and Eye Comfort Eyetamins to its Optase Product Line
Scope Health, of New York, announced June 17 that it had added Eyetamins Vision Support and Eye Comfort versions to its Optase line of eyelid hygiene and ocular lubricant products. The Eye Comfort ...
Ocusoft Introduces Retaine Ultra PF Preservative-Free Artificial Tears
Ocusoft, of Rosenberg, Texas, announced on June 17 the launch of Retaine Ultra PF, a lubricating eye drop available in a preservative-free multi-dose bottle. Its active ingredients include polyethy...
Essential Pharma Appoints Becki Morison as Chief Executive Officer
UK-based Essential Pharma announced June 18 that it had appointed Becki Morison as chief executive officer, effective July 1. Morison succeeds Simon Ball, who has served as interim CEO since Novemb...
Aier Eye Hospital Group to Buy 25 VisuMax 800 Lasers from Zeiss
German company Carl Zeiss Meditec reported June 17 that the Aier Eye Hospital Group in China had agreed to buy 25 VisuMax 800 femtosecond lasers for its hospital locations starting this year. The V...
Johnson & Johnson to Invest $1 Billion in Jacksonville, Home of J&J Vision
Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution capabilities for i...
Belite Bio Completes Rolling NDA Submission for Oral Tinlarebant in Stargardt
Belite Bio announced June 12 that it had completed its rolling new drug application (NDA) submission to the US FDA for oral tinlarebant for the treatment of Stargardt disease. The San Diego, Califo...
2026 ARVO Meeting Draws Big Attendance, Rare Snowstorm
The 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) drew 10,996 attendees, the second largest attendance to date, coming in just under the 2024 total of 11,631. The ...
J&J Expands US Rollout of Tecnis PureSee IOL
Johnson & Johnson reported June 11 that it was expanding availability for the Tecnis PureSee IOL in the US. The lens gained US FDA approval in March 2026. The PureSee is a purely refractive extende...
Alcon Launches Unity CS Phaco System in Canada
Alcon announced June 15 the launch in Canada of the Unity CS phacoemulsification system for cataract surgery. Alcon said it planned to showcase the platform at the Canadian Ophthalmological Society...
Tavo Biotherapeutics Appoints Federico Grossi, MD, PhD, as CMO
Tavo Biotherapeutics, of Laguna Beach, California, announced June 2 that it had appointed Federico Grossi, MD, PhD, as chief medical officer (CMO). Grossi most recently was CMO of Unity Biotechnolo...
TearSolutions Gains Orphan, Fast Track Status for Lacripep in Neurotrophic Keratitis
TearSolutions announced June 2 that the US FDA had granted orphan drug and fast track designations for its synthetic peptide eye drop candidate Lacripep in neurotrophic keratitis (NK). NK is a rare...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.